+

WO1998015505A1 - Production of porous articles - Google Patents

Production of porous articles Download PDF

Info

Publication number
WO1998015505A1
WO1998015505A1 PCT/GB1997/002705 GB9702705W WO9815505A1 WO 1998015505 A1 WO1998015505 A1 WO 1998015505A1 GB 9702705 W GB9702705 W GB 9702705W WO 9815505 A1 WO9815505 A1 WO 9815505A1
Authority
WO
WIPO (PCT)
Prior art keywords
polymerisation
dispersion
foam
article
particles
Prior art date
Application number
PCT/GB1997/002705
Other languages
French (fr)
Inventor
Robert Terence Smith
Rodney Martin Sambrook
Original Assignee
Dytech Corporation Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dytech Corporation Ltd. filed Critical Dytech Corporation Ltd.
Priority to JP10517285A priority Critical patent/JP2001501902A/en
Priority to AU45639/97A priority patent/AU4563997A/en
Priority to EP97943989A priority patent/EP0958261A1/en
Publication of WO1998015505A1 publication Critical patent/WO1998015505A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B38/00Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof
    • C04B38/0038Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by superficial sintering or bonding of particulate matter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B38/00Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof
    • C04B38/06Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances
    • C04B38/0615Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances the burned-out substance being a monolitic element having approximately the same dimensions as the final article, e.g. a porous polyurethane sheet or a prepreg obtained by bonding together resin particles
    • C04B38/062Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances the burned-out substance being a monolitic element having approximately the same dimensions as the final article, e.g. a porous polyurethane sheet or a prepreg obtained by bonding together resin particles the burned-out substance being formed in situ, e.g. by polymerisation of a prepolymer composition containing ceramic powder
    • C04B38/0625Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances the burned-out substance being a monolitic element having approximately the same dimensions as the final article, e.g. a porous polyurethane sheet or a prepreg obtained by bonding together resin particles the burned-out substance being formed in situ, e.g. by polymerisation of a prepolymer composition containing ceramic powder involving a foaming step of the burnable material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00293Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00474Uses not provided for elsewhere in C04B2111/00
    • C04B2111/00836Uses not provided for elsewhere in C04B2111/00 for medical or dental applications

Definitions

  • the invention relates to the production of articles of controlled porosity.
  • the monomeric material is selected to polymerise by cross linking, whereby the liquid carrier and ceramic particles are held within the polymerised structure.
  • the method of this prior patent is arranged to produce a variety of useful articles such as catalyst supports, flame supports; gas filters; air fresheners; ceramic armour; diesel paniculate traps; insulation materials; artificial parts for the body; metal filters, reusable filters; liquid filters; storage and transportation for flammable and/or toxic materials, humidity sensors, chromatography; filter candles for filtration of hot combustion gases, diaphragms, membranes, refractory separators, phase dividers and electrolytes for high temperature fuel cells.
  • useful articles such as catalyst supports, flame supports; gas filters; air fresheners; ceramic armour; diesel paniculate traps; insulation materials; artificial parts for the body; metal filters, reusable filters; liquid filters; storage and transportation for flammable and/or toxic materials, humidity sensors, chromatography; filter candles for filtration of hot combustion gases, diaphragms, membranes, refractory separators, phase dividers and electrolytes for high temperature fuel cells.
  • the decomposition rate of the gas generating substance is controlled. This in turn provides a means of controlling the density of the end product. It is one object of the invention to provide a method of making a porous article having controlled levels of porosity, mterconnectivity, pore size, and mechanical properties suitable for use in various applications.
  • the invention provides a method of making a porous article composed of bonded particles, the method comprising the steps of:
  • the dispersion comprises particles having an average particle size less than about 5 micrometres and preferably 95% of the particles will be less than about 2 micrometres. If the particles are larger than this size than the particles tend to settle or sediment.
  • the particles can be much larger, say 100 micrometres or more, in which case agents will be present to control undesired settling; polymerisation of monomers is a suitable means of preventing settling.
  • the particles will be chosen according to the intended end use. As will be explained later, for the preferred use hydroxyapatite is present either alone or with other particles.
  • the other particles can include both oxides and non-oxides such as alumina, mullite, silicon carbide, silicon nitride, zirconia, titanium oxide and the like.
  • the content of the solids in the dispersion will tend to be about 10% by weight as a nrinimum and about 90% by weight as a maximum; a preferred range is from about 40% to about 80%) by weight.
  • the liquid carrier is water but it may be organic, e.g. alcohol, glycol or the like; or a mixture.
  • dispersing agents are commonly used throughout the ceramic industry and suitable agents in each case can be determined by the man skilled in the art.
  • the colloidal stability may be controlled by the adjustment of the pH, in addition to or alternating to the dispersion
  • surfactants which can be cationic, anionic or non-ionic
  • surfactant type and concentration can have a direct influence not only on the level of porosity within the system but also the pore size and the mterconnectivity.
  • concentration of surfactant can be used to influence the bubble size within a foam and the rate of coalescence, both of which can be used to influence the final pore size.
  • a slurry which exhibits a low degree of pseudoplasticity coupled with a low bulk viscosity is susceptible to foam collapse and rapid bubble growth.
  • a slurry which exhibits a high degree of pseudoplasticity is subject to long term stability and a less rapid bubble growth although at an acceptable level.
  • the bulk viscosity of the system increases the controlling effect of the surfactant diminishes.
  • Another factor which influences the growth of the foam structure is the period before the onset of polymerisation.
  • This period can be controlled by the addition levels of the initiator and catalyst. By controlling these levels as well as the oxygen concentration within the foaming gas the length of time before polymerisation starts can be controlled between an instantaneous polymerisation and one which starts after a period, which can be up to 20 minutes or more.
  • Our evaluations suggest that this period has a major influence on cell structure where the porous article is to be used as a bone substitute.
  • the process of increasing the cell size within a foam can be encouraged by the application of a partial vacuum to a foam before the commencement of polymerisation until after the end of polymerisation. At the end of polymerisation the stable foam is brought back to atmospheric pressure. This additional step to the foaming process can be used to increase the rate at which the final desired large cell size can be achieved.
  • additives may be present, e.g. viscosity control agents, reinforcing fibres or particles, retarders for polymerisation; and the like.
  • the bubbles of gas may be introduced in any convenient way, although the preferred methods are listed in our previous patent.
  • the gas used for foaming can be air, although an inert foaming gas such as nitrogen or argon is preferred.
  • an inert foaming gas such as nitrogen or argon is preferred.
  • a number of cells can be seen in the left hand photo in Figure 1. These cells are formed as a result of introducing a gaseous phase into the ceramic suspension. Where these cells touch there is a tendency for the cell to change shape to maximise the packing density and for the slurry to drain from the point of contact towards the strut.
  • a strut can be seen in the top right hand photo in Figure 1. These struts are the building block for the foam structure. At the point of contact between each cell a thin film of liquid exists. During the later gelling and binder burnout steps this film is removed to leave what we call the cell "windows". These are the connecting holes which interlink adjacent cells and can be clearly seen in the left hand photo in Figure 1. The final structure is that which forms the cell walls and struts.
  • the final articles formed consist essentially of the starting ceramic materials only, so avoiding the need for the removal of residual secondary e.g. inorganic binders.
  • the article can thus consist of ingredients acceptable for medical use, e.g. as bone grafts for orthopaedic, surgical, dental and like uses both for humans and animals. There will always be a need to replace bone lost as a consequence of traumatic or non-traumatic events.
  • Bone substitute materials are available and approved for clinical use. These materials have been successfully used in orthopaedics, dentistry and facial plastic surgery.
  • the porous types which can provide a scaffold for in growth of connective tissue and bone. Studies have shown that pore sizes less than 10 micrometre prevent ingrowth of cells, pore sizes of 15 to
  • 50 micrometre encourages fibro vascular ingrowth; pore sizes of 50-150 micrometre result in osteoid formation; and pore sizes greater than 150 micrometre facilitate the ingrowth of mineralized bone.
  • Different approaches have been taken to try and mimic the hydroxyapatite frame work within both the cortical and cancellous bone.
  • One material is based on the conversion of a coralline structure to hydroxyapatite material.
  • Hydroxyapatite [Ca ⁇ 0 (PO 4 ), (OH) 2 ] is an ideal candidate starting material.
  • This material belongs to a group of calcium phosphates which are being considered as bone substitute materials.
  • the invention is applicable to hydroxyapatite and any other calcium phosphate (where the Ca/P atomic ratio may vary widely).
  • it may be advantageous to create an interconnected structure in another ceramic material such as alumina or zirconia for mechanical property reasons and either use the material as produced, or coated with a more bioactive material such as hydroxyapatite. It is another feature of this invention that the materials known as
  • the polymerisation preferably proceeds by crosslinking of reactive organic monomers.
  • reactive organic monomers include acrylates, such as ammonium acrylate or hydroxyethyl methacrylate; or the like.
  • the monomers are dissolved in water or other liquid carrier to give a premix solution.
  • an initiator and either heat or a catalyst are used to induce free radical vinyl polymerisation.
  • the dispersion includes a monosaccharide such as galactose, which can be condensed to form a dimer, trimer or polymer, to have the same effect.
  • the foamed composition may be allowed or caused to acquire sufficient green strength to allow it to be moved from the parent container or mould.
  • the composition may be subjected to drying to drive off the liquid. In the case of water, drying can be carried out below about 100°C in an oven or using high frequency drying equipment.
  • the pore sizes in the formed article can be controlled remarkable uniform to yield a material with a pre-determined pore size and level of mterconnectivity.
  • the true porosity may range from about 20%> to about 95%>.
  • the article formed is relatively robust after polymerisation and strong enough to be machined after removal of the liquid carrier.
  • the firing temperature and duration are selected according to the nature of the particles, e.g. alumina generally requires a higher sintering temperature than hydroxyapatite.
  • the invention provides a method of making a porous article composed of bonded particles, the method comprising the steps of:
  • This microporous structure can have advantages in certain applications e.g. it may be infilled with certain drugs such as antibiotics or growth factors, to act as a slow release agent at the site of an implant and it appears to encourage the easy attachment of in-growing bone cells compared to a dense microstructure.
  • the formed article may be in a variety of shapes, e.g. in the form of granules, bars, cylinders or rods, blocks or the like.
  • Hydroxyapatite powder, ammonium acrylate monomer, methylenebisacrylamide, water, the ammonium salt of polyacrylate and the ammonium salt of polymethacrylate were mixed together to form a slurry which was subjected to a high shear mixer in order to remove any agglomerates within the slurry. This was transferred to a glove box within which the oxygen concentration was approx. 0.1%).
  • a surfactant TERGITOL TMN10 was introduced into the slurry and the whole was agitated in a mixer designed to introduce air so that a foam will be formed.
  • the amount by which the ceramic solid is foamed is dependant on the final density required, the solids content of the slurry and the shrinkage which will occur at the later stages of drying and firing.
  • the amount of surfactant added determines the extent of foaming, and this was selected to achieve the required final density.
  • Example I The method of Example I was repeated except that the rate of addition of the initiator and the catalyst were selected so that the time before onset of polymerisation was 16 minutes instead of 1.5 minutes.
  • a highly porous foam exhibiting a larger cell size as shown in Figure 7 resulted. It can be seen from the different Figures that the time before the onset of polymerisation has had a major influence on the cell structure.
  • Figure 1 is a general foam
  • Figure 2 is a foam produced in Example I taken after an idle time of 1.5 minutes;
  • Figure 3 is the polymerised foam of Example I fired at 1250°C for 2 hours;
  • Figure 4 is the polymerised foam of Example I fired at 1350°C for 2 hours;
  • Figure 5 is the fired product shown in Figure 3 after being immersed in a bone cell culture for 36 hours
  • Figure 6 is the fired product shown in Figure 4 after being immersed in a bone cell culture for 36 hours
  • Figure 7 is the foam produced in Example II.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ceramic Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Porous Artificial Stone Or Porous Ceramic Products (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)

Abstract

An aqueous dispersion of ceramic particles and containing a polymerisable monomer was foamed before polymerisation, e.g. using a catalyst and initiator, was started.

Description

PRODUCTION OF POROUS ARTICLES
The invention relates to the production of articles of controlled porosity.
In our European patent B-0598783 (Agent's ref: P00914EP) there is described and claimed a method of making a porous refractory article composed of refractory particles, the method comprising the steps of:
a) forming a dispersion comprising particles in a liquid carrier and containing a polymerisable monomeric material b) introducing gas into the dispersion, c) polymerising the foamed structure, d) drying, to remove the liquid carrier to provide a solid article having pores derived from the bubbles; and e) firing to remove the organic binder and to provide a ceramic bond.
Preferably the monomeric material is selected to polymerise by cross linking, whereby the liquid carrier and ceramic particles are held within the polymerised structure.
The method of this prior patent is arranged to produce a variety of useful articles such as catalyst supports, flame supports; gas filters; air fresheners; ceramic armour; diesel paniculate traps; insulation materials; artificial parts for the body; metal filters, reusable filters; liquid filters; storage and transportation for flammable and/or toxic materials, humidity sensors, chromatography; filter candles for filtration of hot combustion gases, diaphragms, membranes, refractory separators, phase dividers and electrolytes for high temperature fuel cells.
In our patent publication WO95/30631 (PCT/GB95/01063, Agents Ref. P01204PCT) there is described and claimed a method of making a porous refractory article, the method comprising the steps of:
forming an aqueous dispersion of refractory particles including a polymerisable monomer component which on polymerisation generates an exotherm
adding a thermally activated gas generating substance
adding agents such as initiator and/or catalyst to cause the polymerisation
adjusting the temperature and/or pressure so that the gas generating substance generates the gas before or during the initial stage of polymerisation of the monomer component whereby the gas forms bubbles which under the heat of the exotherm interconnect to form an interconnected open pore structure.
By controlling the temperature and pressure the decomposition rate of the gas generating substance is controlled. This in turn provides a means of controlling the density of the end product. It is one object of the invention to provide a method of making a porous article having controlled levels of porosity, mterconnectivity, pore size, and mechanical properties suitable for use in various applications.
In one aspect the invention provides a method of making a porous article composed of bonded particles, the method comprising the steps of:
a) forming a dispersion comprising a liquid carrier and the particles and a polymerisable monomeric material; b) foraiing a foam of the dispersion; c) polymerising the foamed structure; d) drying the structure to remove the liquid carrier and provide a solid article having pores derived from the bubbles, and e) firing the article to remove the organic binder and provide a ceramic bond
characterised in that small bubbles of gas are introduced in the dispersion with agitation to form the foam and are allowed or caused to coalesce before the polymerisation.
The dispersion comprises particles having an average particle size less than about 5 micrometres and preferably 95% of the particles will be less than about 2 micrometres. If the particles are larger than this size than the particles tend to settle or sediment.
However, the particles can be much larger, say 100 micrometres or more, in which case agents will be present to control undesired settling; polymerisation of monomers is a suitable means of preventing settling. The particles will be chosen according to the intended end use. As will be explained later, for the preferred use hydroxyapatite is present either alone or with other particles. The other particles can include both oxides and non-oxides such as alumina, mullite, silicon carbide, silicon nitride, zirconia, titanium oxide and the like.
The content of the solids in the dispersion will tend to be about 10% by weight as a nrinimum and about 90% by weight as a maximum; a preferred range is from about 40% to about 80%) by weight.
Conveniently the liquid carrier is water but it may be organic, e.g. alcohol, glycol or the like; or a mixture.
In order to produce a dispersion with the required solids loading and a suitable rheology, it is preferred to add dispersing agents to the suspension. The dispersing agents are commonly used throughout the ceramic industry and suitable agents in each case can be determined by the man skilled in the art. The colloidal stability may be controlled by the adjustment of the pH, in addition to or alternating to the dispersion
agents. Advantageously surfactants (which can be cationic, anionic or non-ionic) are present in the dispersion. In low viscosity systems where the ability of a system to foam is controlled by the surface tension, the surfactant type and concentration can have a direct influence not only on the level of porosity within the system but also the pore size and the mterconnectivity. The concentration of surfactant can be used to influence the bubble size within a foam and the rate of coalescence, both of which can be used to influence the final pore size.
By controlling the rheology of the suspension it is possible to influence the rate of coalescence of the foam structure. A slurry which exhibits a low degree of pseudoplasticity coupled with a low bulk viscosity is susceptible to foam collapse and rapid bubble growth. In contrast a slurry which exhibits a high degree of pseudoplasticity is subject to long term stability and a less rapid bubble growth although at an acceptable level. As the bulk viscosity of the system increases the controlling effect of the surfactant diminishes.
Another factor which influences the growth of the foam structure is the period before the onset of polymerisation. This period can be controlled by the addition levels of the initiator and catalyst. By controlling these levels as well as the oxygen concentration within the foaming gas the length of time before polymerisation starts can be controlled between an instantaneous polymerisation and one which starts after a period, which can be up to 20 minutes or more. Our evaluations suggest that this period has a major influence on cell structure where the porous article is to be used as a bone substitute. In a further feature of the invention the process of increasing the cell size within a foam can be encouraged by the application of a partial vacuum to a foam before the commencement of polymerisation until after the end of polymerisation. At the end of polymerisation the stable foam is brought back to atmospheric pressure. This additional step to the foaming process can be used to increase the rate at which the final desired large cell size can be achieved.
Other additives may be present, e.g. viscosity control agents, reinforcing fibres or particles, retarders for polymerisation; and the like.
The bubbles of gas may be introduced in any convenient way, although the preferred methods are listed in our previous patent. The gas used for foaming can be air, although an inert foaming gas such as nitrogen or argon is preferred. To produce a foam with a large pore structure and a high degree of porosity, one could either introduce bubbles of the correct size and quantity into the suspension or cause smaller bubbles to grow by a process of coalescence. The latter is preferred at the moment.
In order to produce the small bubbles within the foam mechanical agitation is
preferred.
Our investigations have shown that the structure of the foam can be broken into four distinctly different areas:
the cells or bubbles the struts the windows, and finally the paniculate micro structure
These structures can be seen in Figure 1 of the accompanying drawings and are explained as follows.
A number of cells can be seen in the left hand photo in Figure 1. These cells are formed as a result of introducing a gaseous phase into the ceramic suspension. Where these cells touch there is a tendency for the cell to change shape to maximise the packing density and for the slurry to drain from the point of contact towards the strut. A strut can be seen in the top right hand photo in Figure 1. These struts are the building block for the foam structure. At the point of contact between each cell a thin film of liquid exists. During the later gelling and binder burnout steps this film is removed to leave what we call the cell "windows". These are the connecting holes which interlink adjacent cells and can be clearly seen in the left hand photo in Figure 1. The final structure is that which forms the cell walls and struts.
It is a feature of the invention that the final articles formed consist essentially of the starting ceramic materials only, so avoiding the need for the removal of residual secondary e.g. inorganic binders. The article can thus consist of ingredients acceptable for medical use, e.g. as bone grafts for orthopaedic, surgical, dental and like uses both for humans and animals. There will always be a need to replace bone lost as a consequence of traumatic or non-traumatic events. Bone substitute materials are available and approved for clinical use. These materials have been successfully used in orthopaedics, dentistry and facial plastic surgery. Among the types of bone graft materials used, particular interest has been shown in the porous types which can provide a scaffold for in growth of connective tissue and bone. Studies have shown that pore sizes less than 10 micrometre prevent ingrowth of cells, pore sizes of 15 to
50 micrometre encourages fibro vascular ingrowth; pore sizes of 50-150 micrometre result in osteoid formation; and pore sizes greater than 150 micrometre facilitate the ingrowth of mineralized bone. Different approaches have been taken to try and mimic the hydroxyapatite frame work within both the cortical and cancellous bone. One material is based on the conversion of a coralline structure to hydroxyapatite material.
With this process the selection of the coral with the conect pore structure is imperative before conversion takes place. Two corals were eventually selected exhibiting two different pore structures. These two pore structures are intended to replicate the different structures in cortical and cancellous bone. It is a feature of this invention that synthetic articles made by the method may be used as bone graft materials of high acceptability.
Hydroxyapatite [Caι0(PO4), (OH)2] is an ideal candidate starting material. This material belongs to a group of calcium phosphates which are being considered as bone substitute materials. The invention is applicable to hydroxyapatite and any other calcium phosphate (where the Ca/P atomic ratio may vary widely). In addition to this group of materials it may be advantageous to create an interconnected structure in another ceramic material such as alumina or zirconia for mechanical property reasons and either use the material as produced, or coated with a more bioactive material such as hydroxyapatite. It is another feature of this invention that the materials known as
"Bioglass" could be converted in highly porous structures using this method.
The polymerisation preferably proceeds by crosslinking of reactive organic monomers. Examples include acrylates, such as ammonium acrylate or hydroxyethyl methacrylate; or the like. Preferably the monomers are dissolved in water or other liquid carrier to give a premix solution. To this solution are added an initiator and either heat or a catalyst are used to induce free radical vinyl polymerisation. In another variation, the dispersion includes a monosaccharide such as galactose, which can be condensed to form a dimer, trimer or polymer, to have the same effect.
The foamed composition may be allowed or caused to acquire sufficient green strength to allow it to be moved from the parent container or mould. The composition may be subjected to drying to drive off the liquid. In the case of water, drying can be carried out below about 100°C in an oven or using high frequency drying equipment.
The pore sizes in the formed article can be controlled remarkable uniform to yield a material with a pre-determined pore size and level of mterconnectivity. The true porosity may range from about 20%> to about 95%>. The article formed is relatively robust after polymerisation and strong enough to be machined after removal of the liquid carrier. The firing temperature and duration are selected according to the nature of the particles, e.g. alumina generally requires a higher sintering temperature than hydroxyapatite.
In one more specific aspect the invention provides a method of making a porous article composed of bonded particles, the method comprising the steps of:
a) forming a dispersion comprising a liquid carrier and the particles and a polymerisable monomeric material; b) forming a foam of the dispersion; c) polymerising the foamed structure d) drying the structure to remove the liquid carrier and provide a solid article having pores derived from the bubbles, and e) firing the article to remove the organic binder and provide a ceramic
bond.
characterised in that small bubbles of gas are introduced in the dispersion with agitation to form the foam and are allowed or caused to coalesce before the polymerisation, and in that the firing is carried out at a temperature appropriate to the growth of bone cells.
It is a feature of this invention to provide an article having a highly microporous structure if the sintering procedure is controlled. This microporous structure can have advantages in certain applications e.g. it may be infilled with certain drugs such as antibiotics or growth factors, to act as a slow release agent at the site of an implant and it appears to encourage the easy attachment of in-growing bone cells compared to a dense microstructure.
The formed article may be in a variety of shapes, e.g. in the form of granules, bars, cylinders or rods, blocks or the like.
In order that the invention may be well understood it will now be described by way of illustration only by reference to the following examples and micrographs:
Example I
Hydroxyapatite powder, ammonium acrylate monomer, methylenebisacrylamide, water, the ammonium salt of polyacrylate and the ammonium salt of polymethacrylate were mixed together to form a slurry which was subjected to a high shear mixer in order to remove any agglomerates within the slurry. This was transferred to a glove box within which the oxygen concentration was approx. 0.1%). A surfactant TERGITOL TMN10 was introduced into the slurry and the whole was agitated in a mixer designed to introduce air so that a foam will be formed. The amount by which the ceramic solid is foamed is dependant on the final density required, the solids content of the slurry and the shrinkage which will occur at the later stages of drying and firing. The amount of surfactant added determines the extent of foaming, and this was selected to achieve the required final density. Once the foam density was achieved, ammonium persulphate (initiator) and tetramethylethylenediamine (catalyst) were injected into the foam to cause the acrylate monomer to start to polymerise. The time before the onset of polymerisation was about 1.5 minutes.
The mixture was restirred and allowed to stand. Polymerisation began after about 1.5 minutes. A photo of the microstructure produced after an idle time of 1.5 minutes is shown in Figure 2. Once polymerised the foam was removed from the mould and allowed to dry at room temperature for 2 days before being forced dried at 60° C in an oven.
At this point the "green" ceramic can easily be machined into the desired shape. The "green" article was heated in a furnace to remove the organic binder and to cause the ceramic microstructure to density. The sample was split in two and fired at two different temperatures. Sample 1 shown in Figure 3 and sample 2 in Figure 4 were fired at 1250° C for 2 hrs and 1350° C for 2 hrs respectively. It can be seen that the degree of micro structural densification can be adjusted with the sintering conditions. Sample 1 exhibits a highly connected microstructure whereas the micro structural porosity has been removed in sample 2. Live human bone cells were cultured. Both samples 1 and 2 were immersed in the cultures and Figures 5 and 6 show the results after 36 hrs immersion for sample 1 and 2 respectively. The bone cells can be clearly seen on the surface of the cell walls. From these Figures it appears easier for the bone to grow within the undersintered microstructure than the fully densified structure. Example π
The method of Example I was repeated except that the rate of addition of the initiator and the catalyst were selected so that the time before onset of polymerisation was 16 minutes instead of 1.5 minutes. A highly porous foam exhibiting a larger cell size as shown in Figure 7 resulted. It can be seen from the different Figures that the time before the onset of polymerisation has had a major influence on the cell structure.
The Figures of the accompanying drawings are microphoto graphs as follows:
Figure 1 is a general foam;
Figure 2 is a foam produced in Example I taken after an idle time of 1.5 minutes;
Figure 3 is the polymerised foam of Example I fired at 1250°C for 2 hours;
Figure 4 is the polymerised foam of Example I fired at 1350°C for 2 hours;
Figure 5 is the fired product shown in Figure 3 after being immersed in a bone cell culture for 36 hours; Figure 6 is the fired product shown in Figure 4 after being immersed in a bone cell culture for 36 hours; and
Figure 7 is the foam produced in Example II.

Claims

1. A method of making a porous article composed of bonded particles (such as hydroxyapatite or the like) the method comprising the steps of:
a) forming a dispersion comprising a liquid carrier and the particles and a polymerisable monomeric material;
b) forming a foam of the dispersion;
c) polymerising the foamed structure;
d) drying the structure to remove the liquid carrier and provide a solid article having pores derived from the bubbles, and
e) firing the article to remove the organic binder and provide a ceramic bond
characterised in that small bubbles of gas are introduced in the dispersion with agitation to form the foam and are allowed to caused to coalesce before the polymerisation of the monomeric material.
2. A method according to Claim 1, wherein the dispersion comprises particles having an average particle size less than 5 micrometres and preferably 95%> of the particles are less than 2 micrometres.
3. A method according to Claim 1 or 2, wherein the particles are hydroxyapatite, oxides and non-oxides such as alumina, mullite, silicon carbide, silicon nitride, zirconia, titanium oxide; and the like.
4. A method according to any preceding Claim, wherein the content of the solids in the dispersion is 10% to 90%> by weight.
5. A method according to Claim 4, wherein the content of solids is 40%> to 80%> by weight.
6. A method according to any preceding Claim, wherein the liquid carrier is water or organic liquid or a mixture.
7. A method according to any preceding Claim, including the step of adding a dispersing agent to the dispersion.
8. A method according to any preceding Claim including the step of controlling the onset of polymerisation by adjustment of the addition levels of the initiator and catalyst for polymerisation of the monomer.
9. A method according to any preceding Claim, wherein the onset of polymerisation is controlled by adjustment of the concentration of oxygen.
10. A method according to Claim 8 or 9, wherein the period until onset of polymerisation is between an instantaneous polymerisation and 20 minutes.
11. A method according to any preceding Claim, including the step of applying a partial vacuum to a foam before the commencement of polymerisation until after the end of polymerisation, after which the foam is brought back to atmospheric pressure.
12. A method according to any preceding Claim, wherein the product is subjected to drying and firing to form a porous ceramic article.
13. A method according to Claim 12, including the subsequent step of growing bone cells in the porous ceramic product.
14. A method according to Claim 12, wherein the ceramic article has pore sizes greater than 150 micrometres.
15. A method according to Claim 12, including adding a drug to the pores of the article.
16. A method of making a porous article composed of bonded particles, the method comprising the steps of:
a) forming a dispersion comprising a liquid carrier and the particles and a polymerisable monomeric material;
b) forming a foam dispersion;
c) polymerising the foamed structure;
d) drying the structure to remove the liquid carrier and provide a solid article having pores derived from the bubbles, and e) firing the article to remove the organic binder and provide a ceramic bond
characterised in that small bubbles of gas are introduced in the dispersion with agitation to form the foam and are allowed or caused to coalesce before the polymerisation, and in that the firing is carried out at a temperature appropriate to the growth of bone cells.
PCT/GB1997/002705 1996-10-04 1997-10-01 Production of porous articles WO1998015505A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP10517285A JP2001501902A (en) 1996-10-04 1997-10-01 Manufacture of porous articles
AU45639/97A AU4563997A (en) 1996-10-04 1997-10-01 Production of porous articles
EP97943989A EP0958261A1 (en) 1996-10-04 1997-10-01 Production of porous articles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9620752A GB2317887A (en) 1996-10-04 1996-10-04 Porous ceramic articles; bone cell growth and drug carriers
GB9620752.7 1996-10-04

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09269999 A-371-Of-International 1999-06-28
US10/820,627 Continuation US20040253279A1 (en) 1996-10-04 2004-04-08 Production of porous articles

Publications (1)

Publication Number Publication Date
WO1998015505A1 true WO1998015505A1 (en) 1998-04-16

Family

ID=10800966

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/002705 WO1998015505A1 (en) 1996-10-04 1997-10-01 Production of porous articles

Country Status (5)

Country Link
EP (1) EP0958261A1 (en)
JP (1) JP2001501902A (en)
AU (1) AU4563997A (en)
GB (3) GB2317887A (en)
WO (1) WO1998015505A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340648B1 (en) 1999-04-13 2002-01-22 Toshiba Ceramics Co., Ltd. Calcium phosphate porous sintered body and production thereof
DE10113108A1 (en) * 2001-03-15 2002-10-02 Dot Gmbh Calcium phosphate materials containing active ingredient
JP2002543930A (en) * 1999-05-12 2002-12-24 デー アンド イー クライオー シーシー Ceramic wound treatment device
EP1155705A3 (en) * 2000-05-19 2003-10-15 Ochi, Takahiro, Ph. D. Biomaterial
JP2004506679A (en) * 2000-08-21 2004-03-04 ダイテック・コーポレーション・リミテッド Use of porous carriers
US6713420B2 (en) 2000-10-13 2004-03-30 Toshiba Ceramics Co., Ltd. Porous ceramics body for in vivo or in vitro use
US6821916B2 (en) 2001-09-13 2004-11-23 Akira Myoi Ceramics for in vivo use
DE10328892A1 (en) * 2003-06-26 2005-05-12 Curasan Ag Bone building agent and manufacturing process
US6923021B2 (en) 2000-12-21 2005-08-02 Corning Incorporated Method and apparatus for fused silica production
US7514024B2 (en) 2000-12-07 2009-04-07 Hoya Corporation Method for producing a porous sintered body of calcium phosphate-based ceramic

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718672C1 (en) * 1997-05-02 1998-09-24 Zschimmer & Schwarz Gmbh & Co Use of a sugar
GB9821663D0 (en) * 1998-10-05 1998-11-25 Abonetics Ltd Foamed ceramics
GB9825109D0 (en) * 1998-11-16 1999-01-13 Dytech Corp Ltd Porous ceramic matrices
EP1108698B8 (en) * 1999-12-16 2006-10-04 IsoTis N.V. Porous ceramic body
CA2328818A1 (en) 1999-12-16 2001-06-16 Isotis B.V. Porous ceramic body
GB0019003D0 (en) * 2000-08-04 2000-09-20 Lo Wei Jen Porous synthetic bone graft and method of manufacture thereof
GB0020734D0 (en) * 2000-08-22 2000-10-11 Dytech Corp Ltd Bicontinuous composites
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
AU2003256227A1 (en) * 2002-07-30 2004-02-16 Nanyang Technological University Spherical nano-composite powder and a method of preparing the same
JP4215595B2 (en) * 2003-08-21 2009-01-28 安正 赤川 Implant fixing member and implant composite material
WO2007086964A2 (en) 2005-10-21 2007-08-02 University Of South Florida Method of producing interconnected volumetric porosity in materials
CA2965384C (en) 2007-08-09 2021-06-22 The Board Of Regents Of The University Of Texas System Bi-layered bone-like scaffolds
US8044105B2 (en) 2008-02-04 2011-10-25 Dow Global Technologies Llc Water-based ceramic foams showing improved gel strength
WO2011143226A1 (en) 2010-05-11 2011-11-17 Howmedica Osteonics Corp. Organophosphorous, multivalent metal compounds, & polymer adhesive interpenetrating network compositions & methods
WO2012158527A2 (en) 2011-05-13 2012-11-22 Howmedica Osteonics Organophosphorous & multivalent metal compound compositions & methods
CN109512678B (en) * 2018-11-28 2022-04-08 福建工程学院 Preparation method of denture film

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1580935A (en) * 1967-05-18 1969-09-12
US4218255A (en) * 1976-08-30 1980-08-19 University Of Dayton Porous ceramic carriers for controlled release of proteins, polypeptide hormones, and other substances within human and/or other mamillian species and method
DE3108387A1 (en) * 1980-03-05 1982-01-21 The Toyo Rubber Industry Co., Ltd., Osaka Process for producing porous ceramic moulded articles
EP0058867A1 (en) * 1981-02-20 1982-09-01 mundipharma GmbH Method of producing a tricalcium phosphate bone ceramic for application as a bone implant, especially to fill cavities or for setting bone fractures in place after fracture, and tricalcium phosphate ceramic shaped articles produced according to this method
GB2142919A (en) * 1983-07-09 1985-01-30 Sumitomo Cement Co Porous ceramic material and processes for preparing same
US5011495A (en) * 1990-02-16 1991-04-30 The United States Of America As Represented By The Secretary Of The Army Unique bone regeneration tricalcium phosphate
WO1993004013A1 (en) * 1991-08-12 1993-03-04 Dytech Corporation Limited Porous articles
DE4313715A1 (en) * 1993-04-27 1994-11-03 Roehm Gmbh Highly filled, foamed polymer material
WO1995030631A1 (en) * 1994-05-10 1995-11-16 Dytech Corporation Limited Production of ceramic articles
GB2289466A (en) * 1994-05-10 1995-11-22 Dytech Corp Ltd Porous ceramic articles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56166843A (en) * 1980-05-28 1981-12-22 Mitsubishi Mining & Cement Co Filler for bone broken section and void section
JPS6021763A (en) * 1983-07-15 1985-02-04 ティーディーケイ株式会社 Artificial bone material
US4629464A (en) * 1984-09-25 1986-12-16 Tdk Corporation Porous hydroxyapatite material for artificial bone substitute

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1580935A (en) * 1967-05-18 1969-09-12
US4218255A (en) * 1976-08-30 1980-08-19 University Of Dayton Porous ceramic carriers for controlled release of proteins, polypeptide hormones, and other substances within human and/or other mamillian species and method
DE3108387A1 (en) * 1980-03-05 1982-01-21 The Toyo Rubber Industry Co., Ltd., Osaka Process for producing porous ceramic moulded articles
EP0058867A1 (en) * 1981-02-20 1982-09-01 mundipharma GmbH Method of producing a tricalcium phosphate bone ceramic for application as a bone implant, especially to fill cavities or for setting bone fractures in place after fracture, and tricalcium phosphate ceramic shaped articles produced according to this method
GB2142919A (en) * 1983-07-09 1985-01-30 Sumitomo Cement Co Porous ceramic material and processes for preparing same
US5011495A (en) * 1990-02-16 1991-04-30 The United States Of America As Represented By The Secretary Of The Army Unique bone regeneration tricalcium phosphate
WO1993004013A1 (en) * 1991-08-12 1993-03-04 Dytech Corporation Limited Porous articles
DE4313715A1 (en) * 1993-04-27 1994-11-03 Roehm Gmbh Highly filled, foamed polymer material
WO1995030631A1 (en) * 1994-05-10 1995-11-16 Dytech Corporation Limited Production of ceramic articles
GB2289466A (en) * 1994-05-10 1995-11-22 Dytech Corp Ltd Porous ceramic articles

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 9631, Derwent World Patents Index; Class A18, AN 96-308081, XP002035476, ANONYMOUS: "Re-oxygenation during the polymerisation of vinyl monomer MEHQ - by purging with inert gas or reducing solubility of oxygen under partial vacuum, allowing time for adequate mixing" *
RESEARCH DISCLOSURE, vol. 386, no. 003, 10 June 1996 (1996-06-10), EMSWORTH, GB *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340648B1 (en) 1999-04-13 2002-01-22 Toshiba Ceramics Co., Ltd. Calcium phosphate porous sintered body and production thereof
JP2002543930A (en) * 1999-05-12 2002-12-24 デー アンド イー クライオー シーシー Ceramic wound treatment device
EP1155705A3 (en) * 2000-05-19 2003-10-15 Ochi, Takahiro, Ph. D. Biomaterial
JP2004506679A (en) * 2000-08-21 2004-03-04 ダイテック・コーポレーション・リミテッド Use of porous carriers
US6713420B2 (en) 2000-10-13 2004-03-30 Toshiba Ceramics Co., Ltd. Porous ceramics body for in vivo or in vitro use
US7514024B2 (en) 2000-12-07 2009-04-07 Hoya Corporation Method for producing a porous sintered body of calcium phosphate-based ceramic
US6923021B2 (en) 2000-12-21 2005-08-02 Corning Incorporated Method and apparatus for fused silica production
DE10113108A1 (en) * 2001-03-15 2002-10-02 Dot Gmbh Calcium phosphate materials containing active ingredient
DE10113108B4 (en) * 2001-03-15 2007-07-26 Dot Gmbh Active substance-containing calcium phosphate materials
US6821916B2 (en) 2001-09-13 2004-11-23 Akira Myoi Ceramics for in vivo use
DE10328892A1 (en) * 2003-06-26 2005-05-12 Curasan Ag Bone building agent and manufacturing process
US8778374B2 (en) 2003-06-26 2014-07-15 Curasan Ag Bone formation agent and method of production

Also Published As

Publication number Publication date
EP0958261A1 (en) 1999-11-24
GB0100084D0 (en) 2001-02-14
JP2001501902A (en) 2001-02-13
GB2354519B (en) 2001-06-13
GB2354518B (en) 2001-06-13
GB2354519A (en) 2001-03-28
GB2354518A (en) 2001-03-28
GB0100085D0 (en) 2001-02-14
GB9620752D0 (en) 1996-11-20
AU4563997A (en) 1998-05-05
GB2317887A (en) 1998-04-08
GB2354519A8 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
WO1998015505A1 (en) Production of porous articles
US6479418B2 (en) Porous ceramic body
Sopyan et al. Porous hydroxyapatite for artificial bone applications
JP3362267B2 (en) Bioimplant material and method for producing the same
EP1117626B1 (en) Foamed ceramics
Ebaretonbofa et al. High porosity hydroxyapatite foam scaffolds for bone substitute
EP0598783B1 (en) Porous articles
US6977095B1 (en) Process for producing rigid reticulated articles
JP2004532685A (en) Foamed sol-gel and method for producing the same
EP1231951B1 (en) Process for producing rigid reticulated articles
US20040253279A1 (en) Production of porous articles
Swain Processing of porous hydroxyapatite scaffold
CN1762897A (en) Preparation process of degradable foam-like strontium-doped calcium phosphate ceramic bone scaffold
CA2319969A1 (en) Composites
US20040129650A1 (en) Method for the production of a biocompatible polymer-ceramic composite material with a predetermined porosity
EP1108698B1 (en) Porous ceramic body
ENDOPROSTHESIS OM Beketov National University of Urban Economy in Kharkiv
Aizawa et al. Development and biological evaluation of apatite fibre scaffolds with large pore size and high porosity for bone regeneration
Yasuda et al. Preparation of porous hydroxyapatite/α-tricalcium phosphate composites by a colloidal process
Aizawa et al. Fabrication of the Hybrid Materials by the Introduction of Poly (Methylmethacrylate) into the Porous Hydroxyapatite Ceramics
Min et al. Effect of reaction conditions on pore configuration and mechanical property for porous hydroxyapatite prepared by polymer sponge method
Lofton et al. Processing of bioactive ceramics with defined porosity

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997943989

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 517285

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09269999

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1997943989

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1997943989

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载